Tools   Select Another Resource Report Type

http://sourceforge.net/projects/hlaseq/

An open-source software tool for accurate genotyping the human HLA genes from Illumina GA high-throughput sequencing data.

Proper citation: HLASeq (RRID:SCR_004185) Copy   

•   Source: SciCrunch Registry

http://www.rfmh.org/nki/

New York State-funded research Institute, located in Orangeburg, New York.

Proper citation: Nathan S. Kline Institute for Psychiatric Research; New York; USA (RRID:SCR_004334) Copy   

•   Source: SciCrunch Registry

http://pass.cribi.unipd.it/cgi-bin/pass.pl

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 9, 2023. A bisulfite aligner suitable for whole methylome analysis of Illumina and SOLiD reads.

Proper citation: PASS-bis (RRID:SCR_004176) Copy   

•   Source: SciCrunch Registry

http://www.cbcf.org/

The Canadian Breast Cancer Foundation is the leading national volunteer-based organization in Canada dedicated to creating a future without breast cancer. Established in 1986 by a dedicated group of volunteers, the Foundation works collaboratively to fund, support and advocate for: * Relevant and innovative research, * Meaningful education and awareness programs, * Early diagnosis and effective treatment * A positive quality of life for those living with breast cancer. Our fundraising through our annual Canadian Breast Cancer Foundation CIBC Run for the Cure, special events, corporate sponsorship and donations has enabled the Foundation to allocate millions of dollars in grants for breast cancer projects and services since our inception. Addressing the needs of Canadians from coast to coast, the Canadian Breast Cancer Foundation has regional offices in British Columbia/Yukon Territory, Prairies/NWT, Ontario and the Atlantic Region. The Foundation''s central office is located in Toronto. Charitable Registration No. 12799 3608 RR0001

Proper citation: Canadian Breast Cancer Foundation (RRID:SCR_004215) Copy   

•   Source: SciCrunch Registry

https://www.cosmobio.com/

An Antibody supplier

Proper citation: Cosmo Bio Co (RRID:SCR_004296) Copy   

•   Source: SciCrunch Registry

http://www.osiris.com/

Stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Now part of Smith and Nephew.

Proper citation: Osiris Therapeutics (RRID:SCR_004233) Copy   

•   Source: SciCrunch Registry

http://www.mscenter.org/

The Rocky Mountain MS Center is a patient-centered organization dedicated to changing the way we think about and treat MS in order to protect the futures of those living with the disease. Our mission is to improve the lives of people with Multiple Sclerosis (MS) and their families through care, support, education and research. * Medical Care and Support: We offer a comprehensive care approach that maximizes and enhances the brain''s ability to protect and repair itself and to promote quality of life for patients and their families. We incorporate wellness, exercise, diet and stress management, and supportive services in addition to the most progressive medical care. * Education: We empower patients, families and health care providers by sharing what we know. There are 10,000 peer reviewed articles published annually; we sort through that information and share the latest advances. * Research: We are pursuing new treatment approaches to save the brain. We are leading the way to assure that we prevent the silent but ongoing brain damage that results in disability. This means treating early and treating aggressively.

Proper citation: Rocky Mountain MS Center (RRID:SCR_004354) Copy   

•   Source: SciCrunch Registry

http://www.cs.gsu.edu/~serghei/?q=drut

Software for Discovery and Reconstruction of Unannotated Transcripts in Partially Annotated Genomes from High-Throughput RNA-Seq Data.

Proper citation: DRUT (RRID:SCR_004351) Copy   

•   Source: SciCrunch Registry

http://www.kyushu-u.ac.jp/english/

Japanese national university located in Fukuoka, in the island of Kyushu.

Proper citation: Kyushu University; Fukuoka; Japan (RRID:SCR_004149) Copy   

•   Source: SciCrunch Registry

http://www.alzheimer.ie/Home.aspx

The Alzheimer Society of Ireland is the leading dementia specific service provider in Ireland. The Society is a company limited by guarantee and a registered charity - CHY 7868. The Society was founded in 1982 by a small group of people who were caring for a family member with Alzheimer''s Disease or a related dementia. Today, it is a national voluntary organization with an extensive national network of branches, regional offices and services that aims to provide people with all forms of dementia, their families and carers with the necessary support to maximize their quality of life. As the major dementia-specific service provider in Ireland, The Society''s network includes over 100 dementia specific services such as day care centers, home care services, carer support groups, social clubs, a national respite center and an advocacy service. The Society also operates the Alzheimer National Helpline Service offering information and support to anyone affected by Alzheimer''s disease / dementia at 1800 341 341. For a full list of services in your area please see the We Can Help section. The Society comprises over 2,500 members, 300 volunteers and over 700 full and part-time staff. The Society has 6 regional offices and a network of Branches around the country. A number of core functions are operated through our national office including information, policy and research, fundraising, public relations, training and finance.

Proper citation: Alzheimer Society of Ireland (RRID:SCR_004300) Copy   

•   Source: SciCrunch Registry

http://www.guthyjacksonfoundation.org/

The Guthy-Jackson Charitable Foundation is dedicated to funding basic science research to find answers that will lead to the prevention, clinical treatment programs and a potential cure for Neuromyelitis Optica (NMO) Spectrum Disease. The decision to create our Foundation came from a personal family crisis. Our daughter was officially diagnosed with NMO in June 2008. Since that time, we have met with many clinicians and researchers in order to understand what this means for our beautiful daughter and our family. Additionally, we have gathered and read every piece of information and NMO research article that is available on the Web. We are now beginning to understand that NMO is not only considered an orphan disease, but that very little research is available. We met with the All Greater Good Foundation in early July 2008 when it became clear that there is little-to-no funding available to research this rare and often misunderstood disease. We joined hands with the All Greater Good Foundation to immediately begin our work, and thus, The Guthy-Jackson Charitable Foundation was born. The Guthy-Jackson Charitable Foundation is dedicated to funding biomedical research in the search to understand the pathophysiology and biochemistry of NMO Spectrum Disease. It is our greatest hope that together we will reverse the effects of NMO and eventually cure this disease.

Proper citation: Guthy-Jackson Charitable Foundation (RRID:SCR_004441) Copy   

•   Source: SciCrunch Registry

http://dkcoin.org/

THIS RESOURCE IS NO LONGER IN SERVICE, documented October 13, 2014. The resource has moved to the NIDDKInformation Network (dkNET) project. Contact them at info_at_dknet.org with any questions. Database of large pools of data relevant to the mission of NIDDKwith the goal of developing a community-based network for integration across disciplines to include the larger DKuniverse of diseases, investigators, and potential users. The focus is on greater use of this data with the objective of adding value by breaking down barriers between sites to facilitate linking of different datasets. To date (2013/06/10), a total of 1,195 resources have been associated with one or more genes. Of 11,580 total genes associated with resources, the ten most represented are associated with 359 distinct resources. The main method by which they currently interconnect resources between the providers is via EntrezGene identifiers. A total of 780 unique genes provide the connectivity between 3,159 resource pairs across consortia. To further increase interconnectivity, the groups have been further annotating their data with additional gene identifiers, publications, and ontology terms from selected Open Biological and Biomedical Ontologies (OBO).

Proper citation: dkCOIN (RRID:SCR_004438) Copy   

•   Source: SciCrunch Registry

http://www.mpiresearch.com/

MPI Research exists to provide comprehensive discovery, safety evaluation, bioanalytical, and analytical services that meet the requirements of biopharmaceutical, medical device, animal health, and chemical companies as we partner globally to bring safer and more effective products to the world. Our goal is to exceed the expectations of our Sponsors and maintain the highest respect in our industry by providing customized, responsive, and on-time services that add value to our Sponsors'' efforts to discover, develop, and enhance products in regulated international environments. We excel as a high performance, high quality organization because of our scientific knowledge and experience, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships. MPI Research has conducted thousands of drug safety, discovery, bioanalytical, and analytical studies. We offer extensive support and resources including, but not limited to * A wide and diverse range of classes of compounds * All routes of administration except inhalation * Studies with numerous species and models * Comprehensive reporting capabilities Flexibility and ample capacity enable us to * Accommodate multiple requirements simultaneously * Adjust schedules readily * Produce results quickly Responding to a broad spectrum of research needs: Working in partnership with pharmaceutical, biotech, medical device, and chemical companies, we conduct customized preclinical research throughout the discovery and development process, from early proof of concept testing to regulatory submissions, including IND, EPA/OPPTS, NDA, PMA, and 510K.

Proper citation: MPI Research (RRID:SCR_004397) Copy   

•   Source: SciCrunch Registry

http://www.cancer.gov/aboutnci/office-of-director

Proper citation: Office of the NCI Director (RRID:SCR_004391) Copy   

•   Source: SciCrunch Registry

http://kingdevicktest.com/

An accurate and reliable method for identifying athletes with head trauma, and a strong candidate rapid sideline screening test for concussion. The test is able to capture impairments of eye movement, attention, language and other symptoms of impaired brain function. It is a physical method of evaluating visual tracking and saccadic eye movements is based on the time to perform rapid number naming. It involves reading aloud a series of single digit numbers from left to right on three test cards. Participants are asked to read the numbers on each card from left to right as quickly as possible but without making any errors. The sum of the three test card time scores constitutes the summary score for the entire test. The test is a proven indicator of oculomotor inefficiencies regarding eye movements during reading. Published medical studies have determined that deficiencies in saccadic eye movements can be an indicator of mild Traumatic Brain Injury (mTBI) or concussions. Studies have shown that there is a significant relationship between poor oculomotor functions and learning disabilities (including dyslexia detection). Saccadic eye movement deficiencies can be improved with training and correspondingly reading performance also can be improved. Simply put, subjects who don''t perform well on this test are not efficient readers, although because there are many reasons for poor reading unrelated to eye movements, some poor readers do fine on the test. They believe that the test should be in the hands of teachers in order to help them determine if a student''s poor reading performance is related to deficiencies in their ability to move their eyes efficiently.

Proper citation: King-Devick Test (RRID:SCR_004500) Copy   

•   Source: SciCrunch Registry

http://www.cellsciences.com/

An Antibody supplier

Proper citation: Cell Sciences (RRID:SCR_004502) Copy   

•   Source: SciCrunch Registry

https://www.cedarlanelabs.com/

An Antibody supplier

Proper citation: CEDARLANE Laboratories Limited (RRID:SCR_004462) Copy   

•   Source: SciCrunch Registry

http://www.psoriasis.org/

The National Psoriasis Foundation (NPF) is a non-profit, voluntary health agency dedicated to finding a cure for psoriasis and psoriatic arthritis and eliminating their devastating effects through research, advocacy and education. Founded in 1966, the Psoriasis Foundation has evolved to become the leading patient advocacy group for the 7.5 million Americans living with psoriasis and psoriatic arthritis. As emerging research continues to demonstrate the serious, systemic effects of these chronic autoimmune diseases, our highest priority is to find a cure. Guided by our five year-strategic plan, we are moving towards this goal with an integrated approach that leverages the work of members, health care providers, advocates and scientists in four critical areas: * Research: ** Directly supporting the most promising early-stage research and emerging researchers. ** Hosting the world''s largest bank of psoriasis DNA samples. * Advocacy: ** Advancing a public policy agenda to secure more federal funding for psoriasis research. ** Improving access to care for patients. * Education: ** Providing extensive patient education. ** Keeping health care professionals up to date on psoriasis treatment. * Connection: ** Online communities, support networks, mentorship programs. ** Building a grassroots network of volunteers and advocates. * Leadership: ** A volunteer Board of Trustees steers the strategic direction of the National Psoriasis Foundation. ** Our Medical Board, made up of leading national psoriasis experts, provides medical guidance, leadership and advocacy. ** An executive staff of seasoned non-profit leaders drives the organization to achieve its strategic plan goals.

Proper citation: National Psoriasis Foundation (RRID:SCR_004454) Copy   

•   Source: SciCrunch Registry

http://www.wicell.org/

A nonprofit organization offering research and clinical grade pluripotent stem cell lines, cytogenetic testing, quality control testing and cell banking services to researchers worldwide. The organization is focused on enhancing and expanding the study of human pluripotent stem cells by supporting basic research; establishing research protocols; creating and distributing cell lines; providing training to scientists worldwide; and supporting efforts to unlock the therapeutic potential of stem cell technologies. As home to the Wisconsin International Stem Cell (WISC) Bank, and previously the first US National Stem Cell Bank, WiCell serves the worldwide scientific stem cell community through banking, characterization, and distribution of stem cell lines as well as providing technical support. WiCell also offers cytogenetic services, quality control testing services and clinical grade cell lines to researchers across the globe.

Proper citation: WiCell Research Institute (RRID:SCR_004364) Copy   

•   Source: SciCrunch Registry

http://www.roswellpark.edu/

America''s first cancer center founded by Dr. Roswell Park. His revolutionary model of a multidisciplinary approach to cancer with scientists and clinicians working in concert and in consult has become the standard by which all modern-day comprehensive cancer centers are measured. RPCI is among the first and only upstate New York facility to hold the National Cancer Institute designation of comprehensive cancer center and to serve as a member of the prestigious National Comprehensive Cancer Network. Many RPCI faculty serve on the NCCN panels that create the Clinical Practice Guidelines in OncologyTM the internationally recognized standards for clinical policy in oncology, and the most comprehensive, most frequently updated clinical practice guidelines available in any area of medicine. Over its long history, Roswell Park Cancer Institute has made fundamental contributions to reducing the cancer burden and has successfully maintained an exemplary leadership role in setting the national standards for cancer care, research and education. Over the last decade, RPCI has undergone major growth, adding over 1,000 new jobs, initiating one of the nation''s first hospital facilities dedicated to Phase I cancer research studies, and setting itself apart as a leader in surgical robotics, vitamin D research, immunotherapy and vaccine therapy, studies targeting tumor microenvironment and cancer prevention, and the development and testing of new agents and technology. *Research: From its inception, Roswell Park Cancer Institute identified cancer research as a core element of its mission. Since then, groundbreaking research by RPCI scientists has led to greater understanding of the nature of cancer and to major advances in cancer diagnosis and treatment. * Education: Roswell Park''s excellent faculty and strong alliances with the University at Buffalo, as well as other local and regional colleges and universities, enables the Institute to provide a superior, comprehensive education in several fields.

Proper citation: Roswell Park Cancer Institute (RRID:SCR_004471) Copy   

•   Source: SciCrunch Registry